Related Experiment Video
Updated: Aug 31, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Folic acid and methotrexate use and their association with COVID-19 diagnosis and mortality: a case-control analysis
Ruth Topless1, Ralph Green2, Sarah L Morgan3
1Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Insights
Folic acid supplementation was linked to a higher risk of COVID-19 diagnosis and death. Methotrexate prescription did not increase COVID-19 risk and may reduce associated mortality risks.
Area of Science:
- Epidemiology
- Pharmacology
- Infectious Diseases
Background:
- Folic acid and methotrexate are commonly prescribed medications.
- Their potential impact on COVID-19 risk and outcomes is not fully understood.
Purpose of the Study:
- To investigate the association between folic acid or methotrexate prescription and the risk of COVID-19 diagnosis and mortality.
Main Methods:
- A case-control study using UK Biobank data from over 380,000 participants.
- Multivariable logistic regression analyzed COVID-19 diagnosis and mortality, adjusting for numerous covariates.
Main Results:
- Folic acid supplementation was associated with increased COVID-19 diagnosis (OR 1.51) and COVID-19-related death (OR 2.64).
- Methotrexate prescription, with or without folic acid, was not significantly associated with COVID-19 diagnosis or mortality.
Conclusions:
- Folic acid supplementation is associated with higher risks of COVID-19 diagnosis and mortality.
- Methotrexate may potentially mitigate these risks, warranting further investigation.
Objective:
To determine if methotrexate or folic acid prescription was associated with differential risk for COVID-19 diagnosis or mortality.
Design:
Case-control analysis.
Setting:
The population-based UK Biobank (UKBB) cohort.
Participants:
Data from 380 380 UKBB participants with general practice prescription data for 2019-2021. Updated medical information was retrieved on 13 December 2021.
Primary And Secondary Outcome Measures:
The outcomes of COVID-19 diagnosis and COVID-19-related mortality were analysed by multivariable logistic regression. Exposures evaluated were prescription of folic acid and/or methotrexate. Criteria for COVID-19 diagnosis were (1) a positive SARS-CoV-2 test or (2) ICD-10 code for confirmed COVID-19 (U07.1) or probable COVID-19 (U07.2) in hospital records, or death records. By these criteria, 26 003 individuals were identified with COVID-19 of whom 820 were known to have died from COVID-19. Logistic regression statistical models were adjusted for age sex, ethnicity, Townsend deprivation index, body mass index, smoking status, presence of rheumatoid arthritis, sickle cell disease, use of anticonvulsants, statins and iron supplements.
Results:
Compared with people prescribed neither folic acid nor methotrexate, people prescribed folic acid supplementation had increased risk of diagnosis of COVID-19 (OR 1.51 (1.42-1.61)). The prescription of methotrexate with or without folic acid was not associated with COVID-19 diagnosis (p≥0.18). People prescribed folic acid supplementation had positive association with death after a diagnosis of COVID-19 (OR 2.64 (2.15-3.24)) in a fully adjusted model. The prescription of methotrexate in combination with folic acid was not associated with an increased risk for COVID-19-related death (1.07 (0.57-1.98)).
Conclusions:
We report an association of increased risk for COVID-19 diagnosis and COVID-19-related death in people prescribed folic acid supplementation. Our results also suggest that methotrexate might attenuate these associations.
More Related Videos
03:19Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Related Concept Videos
Teratogenicity
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Confounding in Epidemiological Studies
Cancer Survival Analysis
Bias in Epidemiological Studies
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...